A missense mutation in damage‐specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses. Issue 2 (8th May 2017) - Bellone, Rebecca R.
Abstract : Squamous cell carcinoma (SCC) is the most common cancer of the equine eye, frequently originating at the limbus, with the potential to invade the cornea, cause visual impairment, and result in loss of the eye. Several breeds of horses have a high occurrence of limbal SCC implicating a genetic basis for limbal SCC predisposition. Pedigree analysis in the Haflinger breed supports a simple recessive mode of inheritance and a genome‐wide association study ( N = 23) identified a 1.5 Mb locus on ECA12 significantly associated with limbal SCC ( P corrected = 0.04). Sequencing the most physiologically relevant gene from this locus, damage specific DNA binding protein 2 ( DDB2 ), identified a missense mutation (c.1013 C > T p.Thr338Met) that was strongly associated with limbal SCC ( P = 3.41 × 10 −10 ). Genotyping 42 polymorphisms narrowed the ECA12 candidate interval to 483 kb but did not identify another variant that was more strongly associated. DDB2 binds to ultraviolet light damaged DNA and recruits other proteins to perform global genome nucleotide excision repair. Computational modeling predicts this mutation to be deleterious by altering conformation of the β loop involved in photolesion recognition. This DDB2 variant was also detected in two other closely related breeds with reported cases of ocular SCC, the Belgian and the Percheron, suggesting it may also be a SCC risk factor in these breeds. Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous SCC and melanomas, is explained by mutations in DDB2 . Cross‐species comparison remains to be further evaluated. Abstract : What's new? The horse is an important cancer model, as metastasis is often rare compared to humans. In this study, the authors investigated the genetic basis of ocular squamous cell carcinoma (SCC). They were able to map a risk locus to ECA12, and to identify a missense mutation in DDB2, a UV‐damage DNA repair enzyme. The human genetic disorder xeroderma pigmentosum complementation group E can also be explained by mutations in DDB2. These results should aid in detection and prognosis of ocular SCC in horses, and enable interspecies comparisons.